DERMOCORE LTD.
Company number 08089631 · Active · Cambridge CB23 6JN
DERMOCORE LTD. is an active private limited company (company number 08089631) incorporated on 30 May 2012, registered in Cambridge. Its registered activity is wholesale of pharmaceutical goods (SIC 46460). Latest dormant accounts cover the period ending 31 May 2025, showing net assets of −£167k, with 0 employees on average. Net assets were unchanged on the prior period.
By net assets it sits in the bottom quarter of 1,797 comparable companies in the UK (median £3,718, upper quartile £148k).
Key dates
- Incorporated
- 30 May 2012
- Next accounts due
- 28 February 2027 — in 133 days
- Confirmation statement due
- 13 June 2027 — in 238 days
Due dates are expected from Companies House filing rules; confirm on the official register before relying on them.
Activity
- SIC 46460
- Wholesale of pharmaceutical goods
- Accounts type
- Dormant
- Size band
- Micro (Companies Act thresholds)
Financials — 2 periods on record, latest ending 31 May 2025
| Period end | Net assets | Cash | Debtors | Creditors <1y | Turnover | Profit | Employees |
|---|---|---|---|---|---|---|---|
| 31 May 2025 | −£167k | — | — | £35k | — | — | 0 |
| 31 May 2024 | −£167k | — | — | £35k | — | — | — |
- Current ratio
- 0.03 — current liabilities exceed current assets
Figures as filed in iXBRL accounts at Companies House. "—" means the line was not reported in that filing.
Firmoscan score: 35/100 (grade D)
- -15 Negative net assets — Net assets £-166,779 at 2025-05-31
- -8 Current liabilities exceed current assets — Current ratio 0.03
- +8 Established — Incorporated 2012-05-30 (14 years)
A transparent, rules-based score from filed data only: every point lists its evidence. It is not a credit rating or advice.
Ownership and control
- Mr. Jamal Baker — owns 50–75% of shares; holds 50–75% of voting rights; can appoint or remove directors · since 17 September 2016
- Dr. Laurent Blasco — has significant influence or control · since 17 September 2016 · ceased 20 August 2023
- Mr. Flavien Profumo — has significant influence or control · since 17 September 2016 · ceased 20 August 2023
- Innoderm Sarl (corporate entity, France) — owns 25–50% of shares · since 17 September 2016 · ceased 20 August 2023
Persons with significant control hold 25% or more of shares or voting rights. Smaller shareholdings are only listed in confirmation-statement documents.
Similar companies in Cambridge
Same activity (wholesale of pharmaceutical goods), closest in incorporation date.
- QDEM PHARMACEUTICALS LIMITED — Cambridge, inc. Nov 2011
- BM ALLIANCE LIMITED — Linton, inc. Jul 2010
- MUNDIPHARMA MEDICAL COMPANY LIMITED — Cambridge, inc. Oct 2014
- MUNDIBIOPHARMA LIMITED — Cambridge, inc. Oct 2014
- ANANTA INTERNATIONAL LIMITED — Cambridge, inc. Jun 2015
- INFUTECH LIMITED — Cambridge, inc. Mar 2007
Reminders for DERMOCORE LTD.
Get an email before each filing deadline — accounts and confirmation statement — so nothing is late.